These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22802690)

  • 1. An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma.
    Shen M; Gong F; Pang P; Zhu K; Meng X; Wu C; Wang J; Shan H; Shuai X
    Int J Nanomedicine; 2012; 7():3319-32. PubMed ID: 22802690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer.
    Chen Y; Wang W; Lian G; Qian C; Wang L; Zeng L; Liao C; Liang B; Huang B; Huang K; Shuai X
    Int J Nanomedicine; 2012; 7():359-68. PubMed ID: 22848158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An MRI-visible non-viral vector bearing GD2 single chain antibody for targeted gene delivery to human bone marrow mesenchymal stem cells.
    Pang P; Wu C; Shen M; Gong F; Zhu K; Jiang Z; Guan S; Shan H; Shuai X
    PLoS One; 2013; 8(10):e76612. PubMed ID: 24116127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo.
    Chen Y; Lian G; Liao C; Wang W; Zeng L; Qian C; Huang K; Shuai X
    J Gastroenterol; 2013 Jul; 48(7):809-21. PubMed ID: 23179610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An RGD-modified MRI-visible polymeric vector for targeted siRNA delivery to hepatocellular carcinoma in nude mice.
    Wu C; Gong F; Pang P; Shen M; Zhu K; Cheng D; Liu Z; Shan H
    PLoS One; 2013; 8(6):e66416. PubMed ID: 23922634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.
    Luo X; Peng X; Hou J; Wu S; Shen J; Wang L
    Int J Nanomedicine; 2017; 12():5331-5343. PubMed ID: 28794626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells.
    Li G; Hu Z; Yin H; Zhang Y; Huang X; Wang S; Li W
    Int J Nanomedicine; 2013; 8():1293-306. PubMed ID: 23569377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
    Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
    Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy.
    Lu ZX; Liu LT; Qi XR
    Int J Nanomedicine; 2011; 6():1661-73. PubMed ID: 21904456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro.
    Wu Y; Wang W; Chen Y; Huang K; Shuai X; Chen Q; Li X; Lian G
    Int J Nanomedicine; 2010 Mar; 5():129-36. PubMed ID: 20309399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy.
    Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Abnous K; Malaekeh-Nikouei B
    Curr Drug Deliv; 2016; 13(7):1176-1182. PubMed ID: 26718488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
    Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
    Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Small interfering RNA delivery mediated by mPEG-PCL-g-PEI polymer nanoparticles].
    Huang W; Lü M; Gao ZG; Jin MJ; Yang CQ
    Yao Xue Xue Bao; 2011 Mar; 46(3):344-9. PubMed ID: 21626792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-4 receptor-targeted delivery of Bcl-xL siRNA sensitizes tumors to chemotherapy and inhibits tumor growth.
    Guruprasath P; Kim J; Gunassekaran GR; Chi L; Kim S; Park RW; Kim SH; Baek MC; Bae SM; Kim SY; Kim DK; Park IK; Kim WJ; Lee B
    Biomaterials; 2017 Oct; 142():101-111. PubMed ID: 28732245
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Wan X; Sun R; Bao Y; Zhang C; Wu Y; Gong Y
    Mol Pharm; 2021 Nov; 18(11):3990-3998. PubMed ID: 34591491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of hepatocellular carcinoma targeted multifunctional nanocarriers].
    Wu C; Li D; Ren L; Hu X; Jiang Z; Zhu K; Huang M; Guan S; Shan H
    Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(47):3767-70. PubMed ID: 25623105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
    Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
    Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
    Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment.
    Peng Y; Huang J; Xiao H; Wu T; Shuai X
    Int J Nanomedicine; 2018; 13():3467-3480. PubMed ID: 29942129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin.
    Zou S; Cao N; Cheng D; Zheng R; Wang J; Zhu K; Shuai X
    Int J Nanomedicine; 2012; 7():3823-35. PubMed ID: 22888237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.